超敏C-反应蛋白和胰岛素敏感指数在儿童阻塞性睡眠呼吸暂停综合征中的变化

Abstract
Figure/Table
References(23)
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (948 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract OBJECTIVE: To investigate the levels of highsensitivity CRP (hsCRP) and insulin sensitivity index (ISI) in children with obstructive sleep apnea hypopnea syndrome (OSAHS). METHODS: Twenty-nine children with OSAHS and 22 children with primary snoring (PS) were enrolled. Polysomnography was performed. Body mass index (BMI), hsCRP, serum lipids, fasting plasma glucose (FPG), and insulin (INS) were measured. ISI was calculated. RESULTS: The apnea hypopnea index (AHI) in the OSAHS group was higher than that in the PS group (13.2±9.2 vs 1.2±1.1; P<0.05). The lowest oxygen saturation (LSaO2) in the OSAHS group was lower than that in the PS group ［(78.5±5.4)% vs (87.4±3.7)%; P<0.05］. The values of hsCRP in the OSAHS group was higher than those in the PS group (2.8±2.7 mg/L vs 0.6±0.9 mg/L; P<0.05). There were no significant differences in the ISI and serum lipids between the two groups. The hsCRP level was negatively correlated with LSaO2 in the OSAHS group (r=-0.531, P<0.05). CONCLUSIONS: The hsCRP level increases in children with OSAHS. The increased hsCRP level might be associated with an increased risk of cardiovascular diseases.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Jun
	DUO Li-Kun

Key words： Obstructive sleep apnea hypopnea syndrome High-sensitivity CRP Insulin sensitivity index Child

PACS:

R725

Cite this article:

CHEN Jun,DUO Li-Kun. Changes of high-sensitivity CRP and insulin sensitivity index in children with obstructive sleep apnea hypopnea syndrome[J]. 中国当代儿科杂志, 2011, 13(3): 208-211.

CHEN Jun,DUO Li-Kun. Changes of high-sensitivity CRP and insulin sensitivity index in children with obstructive sleep apnea hypopnea syndrome[J]. CJCP, 2011, 13(3): 208-211.

URL:

http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2011/V13/I3/208

	［1］Carroll JL. Obstructive sleep-disordered breathing in children: new controversies, new directions［J］. Clin Chest Med, 2003, 24（2）:261-282.
	［2］刘玺诚，卢秀英，崔振泽.全国8城市2-12岁儿童睡眠状况流行病学调查［J］. 睡眠医学，2004，1(1)：4-7.
	［3］Guilleminault C, Korobkin R, Winkle R. A review of 50 children with obstructive sleep apnea syndrome［J］. Lung, 1981, 159(5):275-287.
	［4］Leung LC, Ng DK, Lau MW, Chan CH, Kwok KL, Chow PY, et al. Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome［J］. Chest, 2006, 130(4):1009-1017.
	［5］Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death［J］. N Engl J Med, 2005, 353（19）:2034-2041.
	［6］Javaheri S, Parker TJ, Liming JD. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations［J］. Circulation, 1998, 97（21）: 2154-2159.
	［7］Capdevila OS, Kheirandish-Gozal L, Dayyat E, Gozal D. Pediatric obstructive sleep apnea: complications, management, and long-term outcomes［J］. Proc Am Thorac Soc, 2008, 5(2):274-282.
	［8］Katz ES, D′Ambrosio CM. Pathophysiology of pediatric obstructive sleep apnea［J］. Proc Am Thorac Soc, 2008, 5(2): 253-262.
	［9］Tharaux PL. Effect of sleep apnea syndrome on the vascular endothelium［J］. Rev Neurol (Paris), 2003,159(11 Suppl):6S102-6S106.
	［10］Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities［J］. Prog Cardiovasc Dis, 2009, 51(4):303-312.
	［11］Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea［J］. Circulation,2002,105(21):2462-2464.
	［12］Ishida K, Kato M, Kato Y, Yanagihara K, Kinugasa Y, Kotani K. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea［J］. Chest, 2009, 136(1):125-129.
	［13］Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdotlir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease［J］. N Engl J Med, 2004, 350(14):1387-1397.
	［14］沈立松. 急性时相蛋白C-反应蛋白的临床意义［J］.临床儿科杂志, 2003,21(4): 253-256.
	［15］Larkin EK, Rosen CL, Kirchner HL, Storfer-lsser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration［J］. Circulation, 2005, 111(15):1978-1984.
	［16］Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells［J］. Circulation, 2002,106(12):1439-1441.
	［17］O′Brien LM, Serpero LD, Tauman R, Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing［J］. Chest, 2006, 129(4): 947-953.
	［18］Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome［J］. Int Heart J, 2005, 46(5):801-809.
	［19］Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children［J］. Am J Respir Crit Care Med, 2007, 176(2): 188-193.
	［20］Li AM, Chan MH, Yin J, So HK, Ng SK, Chan IM, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment［J］. Pediatr Pulmonol, 2008, 43(1): 34-40.
	［21］Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea［J］.Chest, 2004, 125(1):112-117.
	［22］Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type Ⅱ diabetes: a populationbased study［J］. Am J Respir Crit Care Med, 2005, 172(12):1590-1595.
	［23］Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K, Dhingra V, et al. Association between subclinical inflammation & fasting insulin in urban young adult north Indian males［J］.Indian J Med Res, 2006, 124(6): 677-682.